首页 > 产品目录 > 信号通路 > Immunology & Inflammation > COX(Cyclooxygenase) > 依托考昔

依托考昔

ChemLeader 98+%

Etoricoxib (MK-663; MK-0663)

产品编号:CL1843 CAS No.:202409-33-4 MDLNo: 分子式:C18H15ClN2O2S 分子量:358.84
规格 库存 目录价 会员专享价 数量
25 mg 3-5days ¥400.00 登录后可见
- +
50 mg 3-5days ¥650.00 登录后可见
- +
100 mg 3-5days ¥850.00 登录后可见
- +

化学品安全说明书(MSDS)

下载MSDS
  • 基本信息
  • 相关文档
  • 产品详情
  • 相关文献
基本信息
英文名称 Etoricoxib (MK-663; MK-0663)
中文名称依托考昔
CAS号202409-33-4
分子式C18H15ClN2O2S
分子量358.84
外观Light yellow to yellow powder
储存条件 Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
产品详情

Etoricoxib (also known as MK-0663) is a non-steroidal anti-inflammatory drgu (NSAID) which acts as a selective and orally bioactive COX-2 inhibitor, with IC50s of 1.1 μM and 116 μM for COX-2 and COX-1 in human whole blood. Etoricoxib is a synthetic NSAID with antipyretic, analgesic, and potential antineoplastic properties. Etoricoxib binds specifically to and inhibits the enzyme cyclooxygenase-2 (COX-2), resulting in inhibition of the conversion of arachidonic acid into prostaglandins. Inhibition of COX-2 may induce apoptosis and inhibit tumor cell proliferation and angiogenesis.

相关文献
抱歉,暂时没有相关文献
相关产品
抱歉,暂时没有相关产品
在线客服
小德
021-58180488
小立
021-58180488
在线服务时间: 工作日 9:00-18:00